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Abstract

The coronavirus pandemic has presented a wide range of challenges for healthcare
systems in the world. Coronavirus Infectious Disease 2019 has infected millions of people, with
approximately 90% of the population showing mild or no symptoms. The disease has some risk
factors that increase its severity, such as obesity, age, diabetes, cardiovascular diseases,
suppressed immune system, and pulmonary disorders. Obese individuals have higher chances of
having symptomatic COVID-19 infection with excessive rates of hospitalization and ICU
admission. Understanding the mechanisms defining the link between COVID-19 and obesity is
necessary to develop preventive measures and therapeutic interventions for people with obesity.
Patients with obesity suffer from a variety of nutritional deficiencies, which assist in
development of low-grade chronic inflammation. This may result in inappropriate immune
response against viral infections such as COVID-19. This review article proposes that changes in
immune response, nutrition, and respiratory function, are some of the multiple mechanisms of
obesity that increase the risks of developing COVID-19 complications. Patients should make
changes to their lifestyles, focusing on nutrition modification, exercise, and calorie restriction as
well as proper protection from the virus using latest scientific recommendations.

Keywords: Covid-19, obesity, inflammation, immune dysfunction, respiratory function

Introduction
In November 2019, Coronavirus Infectious Disease 2019 (COVID-19) began infecting
people in Hubei, China, causing increased rates of respiratory dysfunction and death. Since then,
the disease has disrupted people’s lives and how businesses and governments are operated.
(Parasher, 2021)
It is caused by a coronavirus with similar charactersitics as the SARS-CoV, which led to
Severe Acute Respiratory Syndrome or SARS in 2003 (Petrakis et al., 2020). The virus
responsible for COVID-19 illness is known as the Severe Acute Respiratory Syndrome
Coronavirus 2 or SARS-COV2 (Parasher, 2021). Transmission is caused by contact of
respiratory droplets coming from an infected individual with another susceptible individual.
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Another way of viral transmission is through indirect contact with surfaces or objects used by an
infected individual (Karia et al. 2020). The body cells are infected when the virus binds to the
angiogensin-converting enzyme 2 (ACE2) and to transmembrane serine protease 2 (TMPRSS2)
(Hoffmann et al. 2020; Wrapp et al. 2020). One of the primary organs that are targeted by Covid19 virus is lungs. The type 2 alveolar cells are specially affected (Zhou et al., 2020). An infected
individual may be asymptomatic or will develop fever, dry cough, sore throat, nausea, diarrhea,
loss of taste and smell, and respiratory illnesses including acute respiratory distress syndrome
(ARDS) and pneumonia (Karia et al., 2020).
The possibility of severe disease and death is increased in patients older than 65 years of
age, and associated comorbidities including obesity, hypertension, diabetes mellitus and immune
deficiency (Poly et al. 2021). Factors related to the disease severity are closely linked to heart
diseases, obesity, and respiratory dysfunction—disorders that increase the risk of COVID-19
complications (Gasmi et al., 2021). Clinical studies indicate a higher number of hospitalized
patients due to Covid-19 were obese. A greater percentage of these individuals were admitted to
ICU and required mechanical ventilation (Simonnet et al., 2020; Qingxian et al., 2020).

Covid-19 and Obesity
Obesity is due to excessive consumption of ultra-processed diets with low nutritional
value, thus causing nutrient deficiencies. Processed foods contain high levels of sodium which
increases the rate of hypertension and cardiovascular conditions. Individuals with obesity have
several micronutrients deficiencies and long-term deficiencies of these nutrients impact the
severity of COVID-19 (Alberca et al. 2020). Obesity causes chronic inflammation, alters
immunity, and vitamin deficiency (Gasmi et al., 2021).
The overall mortality rate of obese patients is 20% higher than general population and the
morbidity rate is twice as high as a person with normal body weight (Lenz et al., 2009).
Although, obesity is a risk factor for severe Covid-19 disease, only a few studies have
investigated the specific contribution of being overweight to the severity of Covid-19 (Kwok et
al., 2020). Higher body mass index has mainly been a critical contributor to the severity of
Covid-19 for patients younger than 65 years of age (Poly et al., 2021). Results showed that
COVID-19 patients with obesity have higher mortality rates as compared to those with average
weights. COVID-19 patients with increased BMI face the risks of intensive care unit, invasive
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mechanical ventilation, and even death. A study in the United States shows that 30% of patients
admitted due to COVID-19 were attributed to obesity (Wadman, 2020). Individuals with high
BMI have higher odds of hospitalization compared with normal-weight individuals. According to
two studies, when obese patients were infected with Covid-19 virus, they were at increased risk
of hospitalization and admission to intensive care (Petrakis et al., 2020; Mohammad et al., 2021).

Effects of obesity in respiratory system
Obesity features like impaired pulmonary function and coexisting disorders such as
diabetes increase the chances of severe COVID-19 complications. In the COVID-19 context,
obesity may increase the risk of virus infection since there is a likelihood for the condition to
cause respiratory dysfunction. This dysfunction is caused by impaired air exchange, reduced lung
volume, low respiratory muscle strength, and increased airway resistance. In addition, people
with obesity are vulnerable to pulmonary hypertension, cardiac arrest, and pneumonia
(Mohammad et al., 2021).
Obesity-related clinical features such as reduced lung capacity, tachypnea, aberrant
respiratory muscle adaption, and reduced chest wall compliance make ventilation in obese
patients more difficult (Alberca et al., 2020). Obesity affects respiratory functions through
several mechanisms, including ventilation-perfusion mismatch, pulmonary restriction, and
muscle fatigue. It adversely affects lung compliance due to the large accumulation of fat within
the thorax cavity. Excess fat in the abdomen pushes on the diaphragm causing decreased chest
cavity and thus restricted airflow. Movement of the chest wall and diaphragm is therefore
limited, resulting in reduced functional residual capacity. These fat deposits in the mediastinum
reduce the compliance of the entire respiratory system by reducing the lung capacity resulting in
the collapse of airways (Alberca et al., 2020). Consecutively this leads to reduced ventilatory
capacity and increased load of the respiratory system. Thus, the respiratory muscle strength for
obese patients is poor because of the increased airway resistance. The stress of a respiratory
infection puts the patients at increased risk for respiratory failure and causes wheeze and
dyspnea, which worsens the prognosis of COVID-19. Moreover, the necessity for invasive
mechanical ventilation increases with the rising levels of obesity. Thus, during the COVID-19
pandemic, obese patients have reduced survival advantage when they come in contract with the
virus (Alberca et al., 2020).
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Obesity and Immune System
Obesity is linked with impairing immune function, thus resulting in significant changes
in the adaptive immune response. The immune system has a crucial responsibility in responding
to disturbances in homeostasis. Obesity alters leucocyte counts, which impairs
immunocompetence, and makes the body more vulnerable to infections. The immune response of
obese people weakens partly because fat cells infiltrate the organs where immune cells are
produced and stored, i.e., bone marrow, spleen, and thymus (Wadman, 2020). In particular, the
adipose tissue invades the organs where immune cells are produced, reducing the immune
response's effectiveness. Changes in the lymphoid tissues adversely impair T-cells activity and
cause diminished immune defense. Fewer immune cells such as T cells do not function well, and
they produce fewer molecules to help destroy virus-infected cells. The overall consequence is
reduced immune response to infectious viruses like the coronavirus. (Wadman, 2020). On the
other hand, the level of CD8+ T cells is increased and the level of CD4+ helper and regulatory T
cells is decreased in adipose tissue. These changes increase the risk of immune activation
(Nishimura et al. 2009).
Obesity is closely related to chronic systemic inflammation. Beyond the condition
impairing the immune response, obese people also suffer from chronic low-grade inflammation.
The adipose tissue is an essential endocrine organ that secretes cytokines and chemokines,
profoundly impacting metabolism and the immune system (Wadman, 2020). It is a vital organ
that is necessary to maintain a balance in the anti-inflammatory and pro-inflammatory
environment. Obesity is closely related to endothelial infection, which is a contributor to proinflammation. Excess calorie consumption leads to expansion of the adipose tissue to store the
excess fat. The excess body fat activates inflammatory reactions, which change the architecture
and function of the tissue. Dysregulated fatty acid metabolism and mitochondrial dysfunction
due to excess fats result in substantial alteration of the cellular structure of the adipose tissues.
Excess adiposity disrupts the balance between pro-inflammatory and anti-inflammatory immune
regulatory cells. Obesity impairs immune response by reducing anti-inflammatory Th-2 cells and
T-cells. The fat cells secrete cytokines that come from macrophages to clean the dead fat cells.
The arrangement thus perpetuates a pro-inflammatory environment. It leads to a state of chronic
low-grade inflammation in obese patients, which is responsible for initiating cytokine storms in
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COVID-19 patients (Wadman, 2020). Chronic inflammation is a severe complication of COVID19 infection. A recent study shows that COVID-19 amplifies acute inflammation resulting in
poorer outcomes. Obesity causes a pro-inflammatory state in the lungs, which compromises
respiratory activity. This leads to increased pro-inflammatory cytokines, thus resulting in chronic
inflammation, a significant complication of COVID-19 infection (Wadman, 2020).
Adipose tissue secretes some hormone such as adipokines and leptin, which affect the
immune system (Francisco et a. 2018). Higher amounts of adipokines and cytokines (TNF-α and
IFNs) are produced in obese individuals. In addition, the level of short chain saturated fatty acids
is higher in these patients. The combined effects of these abnormalities result in low grade
inflammation and reduced response against viral infections (Huttunen et al. 2013). Leptin
influences migration leukocytes and regulates release of oxygen radicals from neutrophils. It also
reduces chemotaxis and increases TNF-α production (Montecucco et al. 2006). Obese patients
have higher level of leptin, which may cause severe lung inflammation in viral infections (Ubags
et al. 2014).

Obesity and Nutritional Imbalance
Obesity and nutrient imbalance affect immune deficiency in a bidirectional way. Some
diets taken by people with obesity contain high amounts of carbohydrates and saturated fat, but
not enough amount of vitamins, minerals, and antioxidants (Martinez et al. 2017). This is the
main reason behind immunodeficiency today since nutrient deficiency impairs immune response
against COVID-19. High-fructose and high-salt diets reduces ACE2 expression in the heart and
in the kidneys. This reduction is associated with higher severity of Covid-19 cases (Bundalo et
al. 2016; Alghatrif et al. 2020). Lack of enough protein intake in obese patients is also associated
with impaired immune response (Hashimoto et al. 2012).
Vitamins and trace elements play a significant role in regulating COVID-19 immune
response. Vitamin deficiency is associated with increased inflammatory cytokines, which
significantly increases respiratory tract infections. T regulatory lymphocytes have been reported
to be low among many obese COVID-19 patients. However, it can be increased by taking
vitamin D supplements. Nutrients have anti-inflammatory and antioxidant properties, which help
the proper functioning of the immune system. Vitamin D deficiency is prevalent among people
with obesity. The deficiency worsens obesity by enhancing lipogenesis and increases infection
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risk. Vitamin D plays a vital role in supporting innate and adaptive immune systems. Research
shows that Vitamins such as A, D play a complementary role in the immune system (Alberca et
al., 2020). Vitamin D is a vital nutritional component that induces antiviral responses. It
influences the secretion of antimicrobial peptides that block viral cellular entry, thus diminishing
the spread of the virus. Individuals with severe obesity have high rates of vitamin D deficiency.
The deficiency of vitamin D has been reported to be a potential factor in susceptibility to
COVID-19. (Margarucci et al., 2021).
Vitamin A is important in the maintenance and regulation of the immune system as well
as normal function of respiratory and intestinal epithelia (Oliveira et al., 2018). When obese
patients who are commonly vitamin A deficient are infected with Covid-19 virus, they may have
cytokine storm and severe viral disease (Huang et al., 2020)
Trace elements such as zinc is important for normal function of immune system. Longterm micronutrient deficiencies such as iron and zinc increase the severity of COVID-19
(Alberca et al., 2020). Iron deficiency is common in obese patients and it reduce T cell and
natural killer cell activation, and impairs immune response against Covid-19 (Bonaccorsi-Riani
et al., 2015; Dao et al., 2013)

Discussion and Conclusion
Global health is challenged by obesity and coronavirus. With the worldwide prevalence
of obesity, it is necessary to explore its relationship with the viral infection. Establishing risk
factors associated with COVID-19 is essential to optimize patient treatment and immunization
distribution. The mechanisms linking obesity and COVID-19 include the state of low-grade
inflammation, nutritional deficiency, and damage to the respiratory system. Obesity makes the
patient vulnerable to COVID-19 by weakening their immune system. Individuals with severe
obesity are deemed more vulnerable to the disease, and therefore, they require special treatment
during the pandemic to avoid further complications and health burdens. Clinical trials and
vaccinations should prioritize the inclusion of people with obesity.
An important lesson from the COVID-19 pandemic is the significance of maintaining a
healthy lifestyle. Some of the healthy promotion measures in preventing obesity can include
eating a non-processed nutrient-rich diet, doing sufficient exercises, and getting adequate sleep.
When the underlying mechanisms are established, proper intervention can be emphasized to
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counter the complications of the disease for the vulnerable groups. What can be done is to eat
healthy foods as well as the appropriate number of calories. Consecutively, this will help with
weight loss and support optimal immune function. Regular physical exercise also helps boost
immune function. Weight loss intervention can have significant benefits during the COVID-19
pandemic. People should follow health advice from experts of getting vitamin supplementation
to prevent deficiency and maintain muscle health during the pandemic.
The limitation of the study is that the current knowledge about obesity increasing the
mortality rates among COVID-19 patients is based on a few observational studies. Further
research should be necessary to establish molecular and cellular mechanisms that cause this
increased risk. More studies should explore the link between these mechanisms and COVID-19
before any conclusions are made.
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